Agenda - Thursday, March 18, 2021

*Recording links accessible next to each session title*

10.00 - 10.45am - Exhibitor Hall & Network Lounge Open

10.45 - 11.45am - Industry Theater - Abiomed   (NON-CME)

View Recording Here

Understanding Coronary Artery Revascularization Strategies to Improve Myocardial Recovery.
Navin Kapur, MD, FAHA, FACC, FSCAI Tufts Medical Center, Boston


Keynote address - View Recording for Keynote Address

"Bridge to Recovery: from Flatlands to Complex Networks"

Sir Magdi Yacoub, MDImperial College London, The Magdi Yacoub Institute London & The Aswan Heart Centre Egypt

1.00pm -2.45pm

The Myocardial Recovery Field in the Coming Post-Pandemic Era - View Recording for Session 1

Chairs: Emma Birks, MD (U of Kentucky) and Daniel Goldstein, MD (Montefiore/Albert Einstein)

  1. RESTAGE-HF multicenter trial: long-term outcomes and implications for HF/Transplant programs. Brian Lowes, MD, PhD U of Nebraska  
  2. Pediatric myocardial recovery and resilience: lessons learned and opportunities. Daniel Zimpfer, MD, Medical University of Vienna, Austria
  3. Global multicenter real world experience with LVAD weaning in chronic HF: short and long-term registry results. Snehal Patel, MD Montefiore/Einstein
  4. Next steps post RESTAGE-HF. Stavros G. Drakos, MD, PhD, U of Utah 

2.45-3.00pm Break - Exhibitor Hall & Network Lounge Open


Myocardial Recovery Programs: “How To” Practical Session - View Recording for Session 2

Chairs: Jen Cowger, MD, MS, FACC (Henry Ford) and Josef Stehlik, MD, MPH (U of Utah) 

  1. Building a recovery program from scratch - the Minneapolis experience. Benjamin Sun, MD, Minneapolis Heart Institute
  2. Building a recovery program from scratch - the Newcastle experience. Guy MacGowan, MD, U of Newcastle, UK
  3. Myocardial recovery: what do the HF patients think and want - live patient participation. Manreet Kanwar, MD, Allegheny 
  4. Patient activation and treatment decisions – lessons from EPIC-HF trial. Larry Allen, MD, U of Colorado


Featured oral presentations of selected abstracts (Non-CME) - View Recording for Oral Abstract Presentations

Chairs: Sihem Boudina, PhD (U of Utah), Rami Alharethi, MD (Intermountain Healthcare) and Omar Wever-Pinzon, MD (U of Utah)

  1. Prolonged intra-aortic balloon pump counterpulsation optimizes right ventricular function before LVAD implantation. Michael Bonios, Onassis Cardiac Surgery Center, Athens, Greece
  2. Cardiomyocyte turnover, ploidy and cell cycle activity in the mechanical unloaded heart. Wouter Derks, Karolinska, Sweden & CRTD-Dresden, Germany
  3. The CorWave Pulsatile Membrane LVAD, a New Tool for Cardiac Recovery, Update and Progress. Trevor Snyder, CorWave, Clichy, France
  4. Role of Endothelial and Mesenchymal cell transitions in heart failure and recovery thereafter. Arvind Bhimaraj, Houston Methodist
  5. Right Ventricular Pressure-Volume Analysis during LVAD Speed Optimization Studies: Insights into Interventricular Interactions and Right Ventricular Failure. Michael Brener, Columbia, New York
  6. Sustainability of Myocardial Recovery and Long-Term Adverse Events Following LVAD Decommissioning. Eleanor Gerhard, Inova Heart and Vascular Institute
  7. Prolonged Support with Temporary VAD for Native Heart Recovery. Shelley Hall, Baylor University Medical Center, Dallas
  8. Myocardial Technetium-99m sestamibi uptake is useful to identify the myocardial reversibility in patients with non-ischemic cardiomyopathy in Stage C and D. Misato Chimura, Osaka School of Medicine, Japan
  9. Phenotyping a new heart failure patient group: Methamphetamine Induced Heart Failure with Reduced Ejection Fraction (MethrEF). Eleni Tseliou, University of Utah

6.00 - 7:30pm Virtual Poster Viewing & Live Chat in Poster Hall